ASCO Releases Studies From Upcoming 2010 Annual Meeting

Yesterday, the American Society of Clinical Oncology (ASCO) made available more than 4,000 medical abstracts which are publicly posted online at A hyperlink to the 2010 ASCO Annual Meeting ovarian cancer abstracts is provided below.  The ASCO Annual Meeting will be held June 4-8, 2010 at McCormick Place in Chicago, Illinois.

The 2010 ASCO Annual Meeting will be held June 4-8, 2010 at McCormick Place in Chicago, Illinois.

Yesterday, the American Society of Clinical Oncology (ASCO) highlighted six studies in a press briefing from among more than 4,000 abstracts publicly posted online at in advance of ASCO’s 46th Annual Meeting.  An additional 14 plenary, late-breaking and other major studies will be released at the Annual Meeting and highlighted in on-site press conferences.

The meeting, which is expected to draw approximately 30,000 cancer specialists, will be held June 4-June 8, 2010, at McCormick Place in Chicago, Illinois. The theme of this year’s meeting is “Advancing Quality Through Innovation.”

“Our growing understanding of cancer’s complex behavior is being translated into better, more targeted drugs against a variety of tumors,” said Douglas W. Blayney, MD, President of ASCO, professor of internal medicine at the University of Michigan Medical School and medical director of the Comprehensive Cancer Center at the University of Michigan. “These studies show that investment in cancer research pays off. We’re developing more personalized approaches to treating patients of all ages and across all cancer types, we’re learning how to use current treatments more effectively, and we’re identifying new ways to help patients live long, healthy lives following treatment.”

“Clinical trials are essential to continued progress against cancer. Yet, the nation’s federally funded clinical trial system is at a breaking point,” said George W. Sledge Jr, MD, ASCO President-Elect, Ballve-Lantero Professor of Oncology and professor of pathology and laboratory medicine at the Indiana University School of Medicine. “ASCO has called for a doubling of support for federally funded clinical cancer research within the next five years. We’ve made impressive strides against this disease, and it’s vital that the nation put more resources into these programs to continue the momentum.

Relevant studies highlighted in the May 20th press briefing include:

  • Promising New Ovarian Cancer Screening Strategy Developed for Post-Menopausal Women at Average Risk: A promising new screening approach for post-menopausal women at average risk of ovarian cancer is feasible and produces very few false-positive results. The method uses a mathematical model combining trends in CA-125 blood test results and a patient’s age, followed by transvaginal ultrasound and referral to a gynecologic oncologist, if necessary.
  • Yoga Improves Sleep and Quality of Life, Lessens Fatigue for Cancer Survivors: Sleep problems and fatigue are among the most common side effects experienced by cancer survivors. A four-week yoga program involving breathing, meditation, postures and other techniques helped cancer survivors sleep better, reduced fatigue and the use of sleep aids, and improved their quality of life.

If you are interested in reviewing the medical abstract subject listing, CLICK HERE.

If you are interested in reviewing the ovarian cancer medical abstracts, CLICK HERE.

Source: ASCO Releases Studies From Upcoming Annual Meeting — – Important Advances in Targeted Therapies, Screening, and Quality of Life, News Release, American Society of Clinical Oncology, May 20, 2010. For a complete PDF copy of the ASCO May 20, 2010 press release, CLICK HERE.